Treatment for Aura

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Aura
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial aims to understand how the brain creates and executes programs of action on the fly, without prior rehearsal.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 7-14 days of neural activity collection

Day 14
Behavioral performance (Accuracy as fraction of correct responses)
Day 14
Neurophysiological activity (single-neuron activity in spikes/second)

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

205 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 7-14 days of neural activity collection

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
914 Previous Clinical Trials
5,981,834 Total Patients Enrolled

Eligibility Criteria

Age < 65 · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: October 8th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.